Histological changes in the hearts of non-survivors of the UK collaborative trial of neonatal ECMO (extra corporeal membrane oxygen)

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 81, Issue 1, 1999, Pages

  Evans, Margaret J ^a   Keeling, J W ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Cardiac pathology; ECMO

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEART VENTRICLE; HUMAN; HUMAN TISSUE; INFANT; INTRACARDIAC THROMBOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; RESPIRATORY TRACT DISEASE; SURVIVAL TIME;

EID: 0033055647     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.81.1.F30     Document Type: Article

References (19)

1. Bartlett R, Andrews A, Toomasian J, et al. Extracorporeal membrane oxygenation (ECAIO) for new born respiratory failure. Surgery 1982;92:425-33.
2. Hill JD, O'Brien TG, Murray JJ, et al. Prolonged extracorporeal membrane oxygénation for acute posttraumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. AT Engl J Med 1972;286:629-34.
3. Sosnowski AW, Bonser SJ, Field DJ, Graham TR, Firmin RK. Extracorporeal membrane oxygénation. BMJ 1990;301:303-4.
4. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygénation and conventional medical therapy in neonates with persistent pulmonary hjpertension of the newborn: A prospective randomized study. Pediatrics 1989;S4:957-63.
5. Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics 1985;76:479-87.
6. Bifano EM, Hakanson DO, Hingre RV, Gross SJ. Prospective randomized controlled trial of conventional treatment or transport for ECMO in infants with persistent pulmonary hypertension (PPHN). Pcdiatr Res 1992;31:196A.
7. Gross SJ, Bifano EM, Gugenio D, Hakanson DO, Hingre RV. Prospective randomised controlled trial of conventional treatment or transport for ECMO in infants with persistent pulmonary hypertension (PPHN): two year follow up. Pcdiatr Res 1994;36:17A.
8. Evans TW, Keogh BF. Extracorporeal membrane oxygénation: A breath of fresh air or yesterday's treatment? Thorax 1991;46:692-4.
9. Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 1989;65:607-22.
10. Field D, Davis C, Elbourne D, Grant A, Johnson A, Macrae D. UK collaborative randomised trial of noenatal extracorporeal membrane oxygénation. Lancet 1996;34S:75-82.
11. Kokai GK, Jovanivic I, Luj'ubic A, Parezanovic V. Aiyocardial infarction in the perinatal period: clinical and histopathological features. Pedialr Pathol Lab filed 1997;17:686-7.
12. Cilley RE, Zwischenberger JB, Andrews AF, Bowerman RA, Roloff DW, Bartlett RH. Intracranial haemorrhage during extracorporeal membrane oxygénation in neonates. Pediatrics 1986;78:699-704.
13. Taylor GA, Fitz CR, Miller MK, Garin DB, Catena LM, Short BL. Intracranial abnormalities in infants treated with extracorporeal memebrane oxygénation: Imaging with US and CT. Radiology 1987;165:675-8.
14. Evans MJ, McKeever PA, Pearson GA, Field D, Firmin RK. Pathological complications of non-survivors of newborn extracorporeal membrane oxygénation. Arch Dis Child 1994;71:F88-F92.
15. Andrews AF, Nixon CA, Cilley RE, Roloff DW, Bartlett RH. One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygénation. Pediatrics 1986;78:692-8.
16. Weber TR, Westfall SH, Sotelo C, Volger CA, Tracy TJ. A clinical-pathological study of nonsurvivors of newborn ECMO. J Pedialr Surgl993;2&:135-7.
17. Vogler C, Sotelo-Avila C, Lagunoff D, Braun P, Schreifels JA, Weber T. Aluminium-containing emboli in infants treated with extracorporeal memebrane oxygénation. AT Engl J Med 1988;319:75-9.
18. Zalles MC, Thibeault DW, Garola RE, Zwick DL. Cardiac pathology in nonsurviving infants treated with extracorporeal membrane oxygénation'. Pcdiatr Palhol Lab Med 1997;17:514.
19. Kinsella JP, Gerstmann DR, Rosenberg AA. The effect of extracorporeal membrane oxygenation on coronary perfusion and regional blood flow distribution. Pediatr Res 1992;31:80-4.